Skip to content

OpenRx Open Medications Explorer

Browse Drugs Ingredients Biologics Veterinary Safety Reports AI Co-Pilot

Browse Filter by letter, class, form, route or application type
Drugs The complete A–Z catalogue
Ingredients Monographs grouped by active ingredient
Biologics Licensed biological products
Veterinary Approved animal drugs and adverse events
Safety Recalls, shortages and post-market signals
Reports Independent research reports and their sources
AI Co-Pilot Regulatory Q&A, MedDRA/VeDDRA coding and openFDA query help
About & data sources

© 2026 OpenRx · public-domain U.S. government data

This resource is provided to you free, as a public benefit.

It does not serve as medical advice, and by using this site you explicitly forfeit your right to sue, hold liable, or in any way blame, Jon "Mike" Schlottig, Leverage AI LLC, and any and all partners and subsidiaries, past present and future, as it relates to information and subsequent decisions made as a result of using this informational resource. Read the full disclaimer

I built this site and unified these databases because I hate when companies obscure valuable and potentially life saving information like this, and thought: "I'm actually fully capable of changing this with a minimal amount of time and effort, I should probably quit complaining and just do it." — Jon "Mike" Schlottig

Leverage AI LLC

Home
Browse
Pharmacologic classes
Glucagon-like Peptide-1 (GLP-1) Agonists

Glucagon-like Peptide-1 (GLP-1) Agonists

15 medication records in the pharmacologic class “Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]”.

15 medications

Byetta exenatide · Injection
Rx NDA TE AP 2 NDC
Exenatide Injection
Rx ANDA TE AP 2 NDC
FOUNDAYO orforglipron · Tablet, Film Coated
Rx NDA 6 NDC
liraglutide Injection
Rx ANDA TE AP1 1 recall 7 NDC
Liraglutide Injection, Solution
Rx ANDA TE AP1 7 NDC
Mounjaro tirzepatide · Injection, Solution
Rx NDA 30 NDC
OZEMPIC oral semaglutide · Tablet
Rx NDA 1 recall 3 NDC
Ozempic semaglutide · Injection, Solution
Rx NDA 6 NDC
RYBELSUS oral semaglutide · Tablet
Rx NDA Shortage 3 NDC
Saxenda liraglutide · Injection, Solution
Rx NDA TE AP2 1 recall 2 NDC
Trulicity Dulaglutide · Injection, Solution
Rx Biologic BLA 2 recalls 11 NDC
Victoza liraglutide · Injection
Rx NDA TE AP1 1 recall 3 NDC
WEGOVY semaglutide · Injection, Solution
Rx NDA 8 NDC
WEGOVY semaglutide · Tablet
Rx NDA 4 NDC
Zepbound tirzepatide · Injection, Solution
Rx NDA 24 NDC

OpenRx

A unified explorer for every publicly documented medication, assembled from fourteen open U.S. government datasets.

Data sources & licensing

Powered by Leverage AI LLC

Explore

Browse everything
Complete A–Z index
Active ingredients
Pharmacologic classes
Dosage forms
Routes of administration

Therapeutics

Human prescription
Over-the-counter
Biologics & biosimilars
Veterinary medicines
Recently approved

Safety

Recalls
Drug shortages
Most reported events
Search

About

About OpenRx
Data sources
Methodology
Disclaimer
Build changelog

Reports

Independent reports
FDA & veterinary databases

Not medical advice. OpenRx is an informational index of public regulatory data. It is not a substitute for the professional judgement of a qualified health professional, and it is not the official FDA labelling. Always consult the manufacturer's current prescribing information and your clinician.

© 2026 OpenRx

Full-text search across medication names, ingredients, manufacturers, pharmacologic classes and official prescribing information.

/ or Ctrl+K to open · Esc to close · dedicated search page